These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15818763)

  • 21. Nisoldipine and myocardial infarction.
    Molitch ME
    N Engl J Med; 1998 Jul; 339(2):126-7; author reply 127. PubMed ID: 9669900
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nisoldipine and myocardial infarction.
    Osende JI
    N Engl J Med; 1998 Jul; 339(2):126; author reply 127. PubMed ID: 9669898
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of angiotensin-converting enzyme inhibitors as monotherapy and in combination with diuretics and calcium channel blockers.
    Cheng A; Frishman WH
    J Clin Pharmacol; 1998 Jun; 38(6):477-91. PubMed ID: 9650536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients.
    Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181
    [No Abstract]   [Full Text] [Related]  

  • 28. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Davis BR; Whelton PK;
    N Engl J Med; 2009 Mar; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of ASCOT on hypertension treatment and guidelines in older adults.
    Sheridan R; Baldwin N
    Age Ageing; 2006 May; 35(3):214-7. PubMed ID: 16638764
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypertension therapies compared. Are the new nevertheless better than the old?].
    MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of hypertension in upheaval?].
    Zidek W; Paul M
    Dtsch Med Wochenschr; 2005 Nov; 130(46):2627. PubMed ID: 16281156
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Tepel M
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs for hypertension.
    Treat Guidel Med Lett; 2005 Jun; 3(34):39-48. PubMed ID: 15912125
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antihypertensive therapy in 357 inpatients of elderly isolated systolic hypertension].
    Zhai LH; Yang CY; Jiang KW; Xu XY; Lu HZ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):719-22, 725. PubMed ID: 16708819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

  • 40. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.